Gioeli Lab: “Improving Diagnostic Capabilities for Prostate Cancer”

February 26, 2021 by

The novel RNA that Gioeli uncovered during his research – and named “HULLK” – has shown it can be detected in urine of prostate cancer patients. This discovery unlocks

the potential to address the unmet medical need for early diagnostics for prostate cancer while also significantly improving patient care by avoiding invasive sample collections from biopsy. In addition to its potential to inform diagnostic tools, this discovery also shows promise of HULLK functioning as a therapeutic target.

[more about this research in the LVG 2020 annual report]